Skip to main content
Clinical Trials/IRCT20170224032753N2
IRCT20170224032753N2CompletedPhase 3

Comparison the Effect of Intravenous Ketamine with Standard Treatment in Migraine Patients Admitted to Emergency Department

Bandare-abbas University of Medical Sciences0 sites46 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
46

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 70 years (—)
Sex
All

Inclusion Criteria

  • Known migraine patients ,referring to emergency department of Shahid Mohammadi hospital in Bandarabbas
  • Age between 18 _ 70 years

Exclusion Criteria

  • history of cardiac disease
  • not complete the written consent
  • oxygen saturation level below 92 percent
  • systolic blood pressure below 90 or over 180 mmHg
  • heart rate below 50 or higher than 120 beat per minute
  • respiratory rate below 10 or higher than 30 per minute
  • consuming any analgesic 4 hour prior to study
  • pregnancy or lactation
  • liver cirrhosis
  • history of drug reaction with morphine or ketamine or other drugs used in the study
  • patients who are on dialysis
  • weight under 45 or more than 115 kg
  • presence of brain mass, chronic pulmonary disease , history of psychosis , or brain damage

Investigators

Sponsor
Bandare-abbas University of Medical Sciences

Similar Trials

Comparison the Effect of Intravenous... | Clinical Trial